Progyny, Inc.

NasdaqGS:PGNY Stock Report

Market Cap: US$1.2b

Progyny Future Growth

Future criteria checks 2/6

Progyny is forecast to grow earnings and revenue by 19.6% and 7.7% per annum respectively. EPS is expected to grow by 21% per annum. Return on equity is forecast to be 16.1% in 3 years.

Key information

19.6%

Earnings growth rate

21.0%

EPS growth rate

Healthcare earnings growth20.7%
Revenue growth rate7.7%
Future return on equity16.1%
Analyst coverage

Good

Last updated02 Dec 2024

Recent future growth updates

Recent updates

Progyny: Rating Downgrade On Uncertain Growth Outlook

Nov 26

Progyny's (NASDAQ:PGNY) Solid Earnings Have Been Accounted For Conservatively

Nov 21
Progyny's (NASDAQ:PGNY) Solid Earnings Have Been Accounted For Conservatively

Progyny: After A Terrible Year, I'm Out (Rating Downgrade)

Nov 18

Here's What's Concerning About Progyny's (NASDAQ:PGNY) Returns On Capital

Oct 21
Here's What's Concerning About Progyny's (NASDAQ:PGNY) Returns On Capital

Progyny: Poor Year Raises Concerns For Future (Downgrade)

Oct 15

Progyny, Inc.'s (NASDAQ:PGNY) Stock Retreats 28% But Earnings Haven't Escaped The Attention Of Investors

Sep 29
Progyny, Inc.'s (NASDAQ:PGNY) Stock Retreats 28% But Earnings Haven't Escaped The Attention Of Investors

Progyny: Downgrading As Uncertainties Increase

Aug 15

Progyny, Inc. (NASDAQ:PGNY) Stocks Pounded By 25% But Not Lagging Market On Growth Or Pricing

Aug 11
Progyny, Inc. (NASDAQ:PGNY) Stocks Pounded By 25% But Not Lagging Market On Growth Or Pricing

At US$27.79, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Jul 20
At US$27.79, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Progyny: Recent Stock Decline Provides Buying Opportunity

Jul 12

Progyny's (NASDAQ:PGNY) Returns Have Hit A Wall

Jun 23
Progyny's (NASDAQ:PGNY) Returns Have Hit A Wall

Progyny: At This Price, Secular Tailwinds Are Too Compelling To Ignore

Jun 10

Progyny: No Change To Long-Term Outlook

Jun 04

Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price

Apr 29
Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price

Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Apr 03
Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Progyny: Long-Term Outlook Remains Positive, Reiterate Buy

Mar 15

Progyny: Long-Term Thesis Still Intact

Mar 09

Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Mar 01
Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Jan 07
Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Dec 11
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Nov 08
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Aug 24
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Aug 06
There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

May 06
Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Jan 25
When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Dec 12
Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Earnings and Revenue Growth Forecasts

NasdaqGS:PGNY - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,303781901948
12/31/20251,1575117517910
12/31/20241,1445216116910
9/30/20241,13957160165N/A
6/30/20241,13363171174N/A
3/31/20241,10861190194N/A
12/31/20231,08962185189N/A
9/30/20231,03352199203N/A
6/30/202395749165169N/A
3/31/202387343109113N/A
12/31/2022787307780N/A
9/30/2022700423538N/A
6/30/2022617463841N/A
3/31/2022551561214N/A
12/31/2021501662426N/A
9/30/2021473902224N/A
6/30/2021450781415N/A
3/31/2021386582425N/A
12/31/2020345463536N/A
9/30/202031032124N/A
6/30/2020272-101115N/A
3/31/2020264-51317N/A
12/31/2019230-9-4-2N/A
9/30/2019194-678N/A
6/30/2019160112N/A
3/31/2019130-400N/A
12/31/2018105-622N/A
12/31/201749-13N/A-9N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PGNY's forecast earnings growth (19.6% per year) is above the savings rate (2.6%).

Earnings vs Market: PGNY's earnings (19.6% per year) are forecast to grow faster than the US market (15.2% per year).

High Growth Earnings: PGNY's earnings are forecast to grow, but not significantly.

Revenue vs Market: PGNY's revenue (7.7% per year) is forecast to grow slower than the US market (9.1% per year).

High Growth Revenue: PGNY's revenue (7.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PGNY's Return on Equity is forecast to be low in 3 years time (16.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:20
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Progyny, Inc. is covered by 20 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhilin LongBerenberg
Nisala WeerasuriyaBerenberg
Allen LutzBofA Global Research